Success Metrics

Clinical Success Rate
100.0%

Based on 27 completed trials

Completion Rate
100%(27/27)
Active Trials
0(0%)
Results Posted
26%(7 trials)

Phase Distribution

Ph phase_2
4
13%
Ph phase_4
1
3%
Ph early_phase_1
1
3%
Ph not_applicable
1
3%
Ph phase_1
22
73%
Ph phase_3
1
3%

Phase Distribution

23

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution30 total trials
Early Phase 1First-in-human
1(3.3%)
Phase 1Safety & dosage
22(73.3%)
Phase 2Efficacy & side effects
4(13.3%)
Phase 3Large-scale testing
1(3.3%)
Phase 4Post-market surveillance
1(3.3%)
N/ANon-phased studies
1(3.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

96.4%

27 of 28 finished

Non-Completion Rate

3.6%

1 ended early

Currently Active

0

trials recruiting

Total Trials

30

all time

Status Distribution
Active(1)
Completed(27)
Terminated(1)
Other(1)

Detailed Status

Completed27
Withdrawn1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
30
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.3%)
Phase 122 (73.3%)
Phase 24 (13.3%)
Phase 31 (3.3%)
Phase 41 (3.3%)
N/A1 (3.3%)

Trials by Status

withdrawn13%
completed2790%
not_yet_recruiting13%
unknown13%

Recent Activity

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT05931484Phase 2

Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.

Not Yet Recruiting
NCT06064539Phase 1

Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

Completed
NCT06809608Phase 1

A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081

Completed
NCT05959447Phase 1

Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant

Completed
NCT02770222Phase 1

A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects

Completed
NCT06392659Phase 1

A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy Adults

Completed
NCT05932303Phase 1

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Completed
NCT04956627Phase 1

A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

Completed
NCT05069870Phase 1

A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy Subjects

Unknown
NCT03723395Phase 1

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

Completed
NCT02045056Early Phase 1

Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease

Completed
NCT03624959Phase 1

Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A

Completed
NCT01836198Phase 1

The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream

Completed
NCT02638597Phase 2

Gemfibrozil for Nicotine Smoking Cessation

Completed
NCT01736254Phase 1

A Study of Evacetrapib in Healthy Participants

Completed
NCT01340846Phase 1

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Completed
NCT01376232Phase 1

Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)

Completed
NCT01876810Phase 2

Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction

Completed
NCT02230033Phase 1

Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927

Completed
NCT00474201Not Applicable

Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil

Completed

Drug Details

Intervention Type
DRUG
Total Trials
30